Luge and the Lab@the scientist
As director of the Human Performance Lab at Boise State University and the author of nine fitness and wellness books, kinesiologist Werner Hoeger understands body movement. This month in Torino, Italy, the 52-year-old professor will put his theories to the test: He’ll be competing in luge at the 2006 Olympic Games.?
for sports scientists, coaches, and athletes to enhance performance and to develop a sports system (high performance coaching, integrated sports science, information management, performance analysis, talent ID, youth development, coach education, and athlete career support)
20 February 2006
15 February 2006
UK Sport funding strategy
UK Sport releases 2012 Funding submission@UK sport
UK Sport has today released its submission to the Government on options for increased funding for elite athletes in the run up to London 2012. The submission is based on the agency’s ‘no compromise’ approach to delivering performance success.
UK Sport has today released its submission to the Government on options for increased funding for elite athletes in the run up to London 2012. The submission is based on the agency’s ‘no compromise’ approach to delivering performance success.
07 February 2006
01 February 2006
Gene Doping and Olympic Sport
Gene Doping and Olympic Sport@SIRC
Education is vital. Athletes and the people athletes rely on for advice need to understand the complexities and uncertainties around gene transfer—not least, our enormous ignorance about the risks of gene transfer in humans, risks that the X-SCID experiment demonstrates can be unexpected and grave.
Research is also crucial. We need to devise strategies to deter and detect gene doping. We also must refine our understanding of the ethics of genetic enhancement. Does gene-doping challenge our conception of natural talents? In what ways is it similar to or different from using performance-enhancing drugs?
Education is vital. Athletes and the people athletes rely on for advice need to understand the complexities and uncertainties around gene transfer—not least, our enormous ignorance about the risks of gene transfer in humans, risks that the X-SCID experiment demonstrates can be unexpected and grave.
Research is also crucial. We need to devise strategies to deter and detect gene doping. We also must refine our understanding of the ethics of genetic enhancement. Does gene-doping challenge our conception of natural talents? In what ways is it similar to or different from using performance-enhancing drugs?
Subscribe to:
Posts (Atom)